Difficulty: Medium
Average Score: 62%
Practice
Which of the following agents is an alphaÔéé-selective agonist with ability to promote constriction of the nasal mucosa?
Correct answer
A
Rationale
In this question, the correct answer is A) Xylometazoline. Xylometazoline is an alphaÔéé-selective agonist that acts to constrict the nasal mucosa. This vasoconstriction helps in reducing nasal congestion by decreasing blood flow to the nasal mucosa, thereby relieving symptoms of stuffiness and congestion. This mechanism of action makes it a popular ingredient in nasal decongestant sprays and drops.
Looking at the other options:
B) Phenylephrine is also an alphaÔéü-selective agonist, but it is not as selective for alphaÔéé receptors as xylometazoline, making it less effective in promoting constriction of the nasal mucosa.
C) Methoxamine is an alphaÔéü-selective agonist, which does not have the same mechanism of action as xylometazoline in promoting nasal constriction.
D) Epinephrine is a non-selective adrenergic agonist, which means it acts on both alpha and beta receptors and does not specifically target the alphaÔéé receptors involved in nasal constriction.
Understanding the differences in the selectivity of adrenergic agonists is crucial in pharmacology as it helps healthcare providers choose the most appropriate medication for specific conditions. Knowing the specific actions of each drug aids in optimizing treatment outcomes and minimizing side effects.
Looking at the other options:
B) Phenylephrine is also an alphaÔéü-selective agonist, but it is not as selective for alphaÔéé receptors as xylometazoline, making it less effective in promoting constriction of the nasal mucosa.
C) Methoxamine is an alphaÔéü-selective agonist, which does not have the same mechanism of action as xylometazoline in promoting nasal constriction.
D) Epinephrine is a non-selective adrenergic agonist, which means it acts on both alpha and beta receptors and does not specifically target the alphaÔéé receptors involved in nasal constriction.
Understanding the differences in the selectivity of adrenergic agonists is crucial in pharmacology as it helps healthcare providers choose the most appropriate medication for specific conditions. Knowing the specific actions of each drug aids in optimizing treatment outcomes and minimizing side effects.